Technical Analysis for STLT - Spotlight Innovation Inc

Grade Last Price % Change Price Change
grade D 0.0094 0.00% 0.0000
STLT closed unchanged on Monday, January 27, 2020, on 6 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical STLT trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
50 DMA Support Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Crossed Above 20 DMA Bullish -4.08%
Crossed Above 50 DMA Bullish -4.08%
Older signals for STLT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Spotlight Innovation Inc., formerly American Exploration Corporation, is a bioscience company. The Company is focused on acquiring the rights, through acquisition, license or otherwise, to various technologies. The Company is engaged in identifying and targeting technology candidates, including cancer drugs and treatment therapies for various disease states; drug and related treatment therapies for various infectious diseases, and other technology candidates. The Company focuses on diseases that are rare, which are known as orphan diseases, or new or common but underserved, such as feline chronic kidney disease. As of December 31, 2015, the Company had three subsidiaries: Celtic Biotech Iowa, Inc., CDT Veterinary Therapeutics, Inc. and Memcine Pharmaceuticals, Inc. Through its subsidiary, Celtic Biotech Iowa, Inc., it develops a range of drug candidates, such as Crotoxin, Cardiotoxin, VRCTC310 and Crotamine. Through its subsidiary, Memcine Pharmaceuticals, Inc., it offers Immunoplex.
Cancer Life Sciences Diseases Infectious Diseases Disease Iowa Orphan Diseases Spotlight Innovation Janssen Biotech Urbandale

Is STLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.123
52 Week Low 0.002
Average Volume 15,622
200-Day Moving Average 0.0183
50-Day Moving Average 0.0077
20-Day Moving Average 0.0054
10-Day Moving Average 0.0065
Average True Range 0.0025
ADX 20.64
+DI 44.6991
-DI 30.0860
Chandelier Exit (Long, 3 ATRs ) 0.0025
Chandelier Exit (Short, 3 ATRs ) 0.0110
Upper Bollinger Band 0.0100
Lower Bollinger Band 0.0008
Percent B (%b) 0.93
BandWidth 170.3704
MACD Line 0.0004
MACD Signal Line -0.0002
MACD Histogram 0.0007
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0094
Resistance 3 (R3) 0.0094 0.0094 0.0094
Resistance 2 (R2) 0.0094 0.0094 0.0094 0.0094
Resistance 1 (R1) 0.0094 0.0094 0.0094 0.0094 0.0094
Pivot Point 0.0094 0.0094 0.0094 0.0094 0.0094
Support 1 (S1) 0.0094 0.0094 0.0094 0.0094 0.0094
Support 2 (S2) 0.0094 0.0094 0.0094 0.0094
Support 3 (S3) 0.0094 0.0094 0.0094
Support 4 (S4) 0.0094